Skip to main content
. 2022 May 31;6(6):e723. doi: 10.1097/HS9.0000000000000723

Figure 1.

Figure 1.

Radiological progression by MRI of PML-associated brain changes from June 2019 (before starting venetoclax, A) to end of July 2019 (8 weeks after venetoclax start, B) and November 2019 (5 months after venetoclax start). Reduction of PML-associated alterations in May 2020 (4 months after pembrolizumab start).